Fundamental rights implications in biotechnology including article 14 equality article 19 freedoms and article 21 right to life and health

Introduction

Biotechnology involves the application of biological sciences, genetic engineering, molecular biology and advanced scientific techniques to develop products and services in healthcare, agriculture, pharmaceuticals and environmental protection. Although biotechnology promotes scientific progress, it also raises important constitutional questions concerning equality, individual freedom, privacy, health, dignity and human rights.

In India, the Constitution provides protection against the misuse of scientific technologies through Fundamental Rights. Articles 14, 19 and 21 are particularly important because they regulate government action and establish safeguards for individuals affected by biotechnology-related activities.

Article 14: Right to equality

Article 14 guarantees equality before the law and equal protection of the laws to every person within India's territory.

Biotechnology may create equality-related concerns when access to scientific developments is restricted or when individuals are discriminated against because of their genetic characteristics, health conditions or biological information.

Major implications include:

Genetic discrimination: Individuals should not face arbitrary discrimination based on genetic information or inherited medical conditions.

Equal access to healthcare: Biotechnology-based medicines, diagnostic services and advanced treatments should be made accessible through fair and non-arbitrary policies.

Fair regulatory treatment: Biotechnology companies and research institutions should be regulated according to consistent legal standards.

Protection of vulnerable groups: Government policies should prevent disadvantaged communities from being excluded from the benefits of scientific development.

For example, denying access to healthcare solely because of a person's genetic predisposition may raise serious equality and dignity concerns.

Important case law:

E.P. Royappa v. State of Tamil Nadu (1974): The Supreme Court explained that arbitrariness is inconsistent with equality under Article 14. This principle is relevant when biotechnology regulations or healthcare policies create unreasonable distinctions between similarly situated individuals.

Article 19: Fundamental freedoms

Article 19 guarantees certain freedoms to Indian citizens, including freedom of speech and expression, peaceful assembly, association, movement and profession or occupation.

Biotechnology affects these freedoms in several ways.

1. Freedom of scientific expression

Researchers and scientists should be able to communicate scientific findings, publish research and participate in academic discussions, subject to lawful restrictions.

2. Freedom of occupation

Article 19(1)(g) protects the right to practise a profession or carry on an occupation, trade or business. Biotechnology companies and scientific entrepreneurs may rely on this protection when establishing research and manufacturing activities.

However, Article 19(6) permits reasonable restrictions in the interests of the general public and allows professional qualifications to be prescribed.

3. Freedom of association

Scientists, research organisations and biotechnology professionals may form associations to promote scientific development, professional interests and research collaboration.

4. Public participation

Citizens should have opportunities to express concerns about genetically modified crops, gene editing, synthetic biology and other emerging technologies through lawful public consultation processes.

Important case law:

Bennett Coleman & Co. v. Union of India (1973): The Supreme Court recognised the importance of freedom of the press under Article 19(1)(a). The judgment is relevant to biotechnology because scientific information and public debate concerning emerging technologies form part of freedom of expression.

Article 21: Right to life, health and personal liberty

Article 21 provides that no person shall be deprived of life or personal liberty except according to procedure established by law. Judicial interpretation has expanded this protection to include dignity, privacy, health and bodily autonomy.

Biotechnology directly affects Article 21 because scientific developments may involve genetic testing, reproductive technologies, clinical trials, biological data and medical interventions.

1. Right to health

Individuals should be protected against unsafe medicines, defective medical technologies and hazardous biological products. Government authorities must establish appropriate regulatory systems to protect public health.

2. Right to privacy

Genetic information can reveal highly personal details about individuals and their families. Its collection, storage and use must comply with applicable privacy protections.

3. Bodily autonomy and informed consent

Individuals should receive appropriate information before participating in medical research or undergoing biotechnology-based treatment. Consent must be voluntary and informed, subject to applicable legal exceptions.

4. Reproductive autonomy

Reproductive biotechnology, assisted reproductive technologies and genetic testing raise questions concerning personal choice, dignity and family autonomy.

5. Environmental health

Biotechnology activities that may create environmental risks must be regulated to protect human life and ecological well-being.

Important case laws concerning Article 21

1. K.S. Puttaswamy v. Union of India (2017)

The Supreme Court unanimously recognised privacy as a fundamental right under Article 21 and other constitutional freedoms.

The judgment is particularly relevant to genetic testing, genomic databases, biometric information and the collection of sensitive biological data.

2. Suchita Srivastava v. Chandigarh Administration (2009)

The Supreme Court recognised reproductive choice as an important aspect of personal liberty under Article 21.

The judgment is relevant to reproductive biotechnology, assisted reproduction and medical decisions involving pregnancy.

3. Paschim Banga Khet Mazdoor Samity v. State of West Bengal (1996)

The Supreme Court held that providing adequate medical facilities is an important obligation of the State under Article 21.

This principle is relevant to ensuring equitable access to biotechnology-based healthcare and essential medical treatment.

4. Common Cause v. Union of India (2018)

The Supreme Court recognised the right to die with dignity and addressed the legal validity of advance medical directives.

The judgment is relevant to biotechnology and advanced medical treatment because it emphasises patient autonomy, dignity and informed medical decision-making.

Relationship between Articles 14, 19 and 21

The three constitutional provisions operate together to establish a comprehensive framework for biotechnology governance.

For example, a government policy restricting access to genetic testing may raise Article 14 concerns if it creates arbitrary discrimination. Restrictions on scientific publication may involve Article 19, while unauthorised collection of genetic information may violate Article 21.

International legal framework

Several international instruments reinforce these constitutional principles:

Universal Declaration of Human Rights, 1948: Protects equality, dignity, privacy and the right to an adequate standard of living.

International Covenant on Civil and Political Rights, 1966: Protects privacy, equality and freedom of expression.

International Covenant on Economic, Social and Cultural Rights, 1966: Recognises the right to the highest attainable standard of physical and mental health under Article 12.

UNESCO Universal Declaration on Bioethics and Human Rights, 2005: Establishes principles concerning human dignity, informed consent, privacy and social responsibility.

Challenges in protecting fundamental rights

Biotechnology creates several constitutional challenges:

Preventing discrimination based on genetic characteristics.

Protecting personal genetic and medical information.

Ensuring affordable access to advanced healthcare.

Balancing scientific freedom with public safety.

Preventing unethical experimentation and involuntary medical procedures.

Establishing accountability for harmful biotechnology applications.

Conclusion

Fundamental Rights play an essential role in regulating biotechnology in India. Article 14 protects equality and prevents arbitrary discrimination, Article 19 safeguards scientific expression and lawful professional activities, while Article 21 protects life, health, privacy, dignity and bodily autonomy. Judicial decisions such as K.S. Puttaswamy, Suchita Srivastava and Paschim Banga Khet Mazdoor Samity provide important constitutional principles for addressing biotechnology-related concerns. A balanced legal framework must encourage scientific innovation while ensuring that technological progress does not undermine human dignity, equality or fundamental freedoms.